Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d]oxazol-2-amine (SKA-121)

Brandon M. Brown, Heesung Shim, Miao Zhang, Vladimir Yarov-Yarovoy and Heike Wulff
Molecular Pharmacology July 31, 2017, mol.117.109421; DOI: https://doi.org/10.1124/mol.117.109421
Brandon M. Brown
1 Univesity of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heesung Shim
2 University of Calfornia, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miao Zhang
3 Chapman University School of Pharmacy, Irvine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Yarov-Yarovoy
4 University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heike Wulff
5 Unviersity of California, Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

mol.117.109421
DOI 
https://doi.org/10.1124/mol.117.109421
PubMed 
28760780

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online July 31, 2017.

Article Versions

  • You are currently viewing an Earlier version of this article (July 31, 2017 - 05:50).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Brandon M. Brown1,
  2. Heesung Shim2,
  3. Miao Zhang3,
  4. Vladimir Yarov-Yarovoy4, and
  5. Heike Wulff5,*
  1. 1 Univesity of California, Davis;
  2. 2 University of Calfornia, Davis;
  3. 3 Chapman University School of Pharmacy, Irvine;
  4. 4 University of California, Davis;
  5. 5 Unviersity of California, Davis
  1. ↵*Address correspondence to: hwulff{at}ucdavis.edu

Statistics from Altmetric.com

Article usage

Article usage: July 2017 to December 2023

AbstractFullPdf
Jul 20172505
Aug 20171620115
Sep 20172645750
Oct 20171272828
Nov 201779811
Dec 201711178
Jan 20181081511
Feb 201890714
Mar 20188966
Apr 20187246
May 20187955
Jun 20186855
Jul 201851310
Aug 20186867
Sep 20181310910
Oct 2018109711
Nov 2018710520
Dec 2018410817
Jan 20193948
Feb 2019166612
Mar 2019114451
Apr 2019132932
May 2019122118
Jun 2019102016
Jul 201972226
Aug 2019163218
Sep 201993116
Oct 2019102014
Nov 201992012
Dec 2019152715
Jan 2020202322
Feb 2020113016
Mar 2020163910
Apr 202082918
May 202011156
Jun 202081613
Jul 2020101924
Aug 2020221918
Sep 2020141724
Oct 2020171820
Nov 2020181919
Dec 2020201411
Jan 2021241829
Feb 2021161712
Mar 202119187
Apr 2021211511
May 2021222913
Jun 202132117
Jul 20212277
Aug 2021251621
Sep 2021291914
Oct 2021363226
Nov 2021292719
Dec 2021302716
Jan 2022314217
Feb 2022242610
Mar 2022162711
Apr 2022193611
May 2022233621
Jun 2022192810
Jul 2022243411
Aug 202217206
Sep 2022242717
Oct 202220356
Nov 2022172817
Dec 202222237
Jan 202322256
Feb 202318223
Mar 2023172711
Apr 2023243111
May 202317207
Jun 202316236
Jul 2023243332
Aug 2023162221
Sep 202334317
Oct 20234713
Nov 20236437
Dec 20231101

Next
Back to top

In this issue

Molecular Pharmacology: 104 (6)
Molecular Pharmacology
Vol. 104, Issue 6
1 Dec 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d]oxazol-2-amine (SKA-121)
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d]oxazol-2-amine (SKA-121)

Brandon M. Brown, Heesung Shim, Miao Zhang, Vladimir Yarov-Yarovoy and Heike Wulff
Molecular Pharmacology July 31, 2017, mol.117.109421; DOI: https://doi.org/10.1124/mol.117.109421

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d]oxazol-2-amine (SKA-121)

Brandon M. Brown, Heesung Shim, Miao Zhang, Vladimir Yarov-Yarovoy and Heike Wulff
Molecular Pharmacology July 31, 2017, mol.117.109421; DOI: https://doi.org/10.1124/mol.117.109421
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics